Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

instruments, net of $2,005 as well as a gain on the extinguishment of a portion of the debt acquired from Indevus of $4,025.
  • To reflect the cash tax savings resulting from the Indevus acquisition and the tax effect of the pre-tax adjustments above at applicable tax rates.
  •     Nine months Ended         Actual
         September 30, 2008      Reported
         (unaudited)               (GAAP)  Adjustments        Adjusted
    
        Total Revenues           $913,200            $        $913,200
        Costs and expenses:
          Cost of revenues        190,554      (21,944)  (1)   168,610
          Selling, general and
           administrative         357,775      (12,481)  (2)   345,294
          Research and
           development             82,244      (10,491)  (3)    71,753
          Impairment of other
           intangibles              8,083       (8,083)  (4)
    
        Operating income          274,544       52,999         327,543
    
          Interest income, net     (8,292)      (6,620)  (5)   (14,912)
          Other income, net          (835)                        (835)
    
        Income before income
         taxes                    283,671       59,619         343,290
          Income taxes            101,021       22,631   (6)   123,652
    
        Net income               $182,650      $36,988        $219,638
    
        Diluted earnings per share  $1.45           --           $1.74
        Diluted weighted
         average shares           126,012           --         126,012
    
    
    
    

    Notes to reconciliation of our GAAP statements of operations to our adjusted statements of operations:

    1. To exclude amortization of commercial intangible assets related to marketed products.
    2. To exclude separation costs of $10,459, impairment of long-lived assets of $1,482 and contract termination costs of $540.
    3. To exclude upfront and milestone payments to partners of $2,000, separation costs of $825, impairment of long lived assets of $3,115 and contract termination costs of $4,551.
    4. To exc
      '/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
    2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
    3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
    5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
    6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
    7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
    8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
    9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
    10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
    11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2014 AARP Foundation today announced it has established a ... the severe cold weather that has gripped much of the ... in need; so to support these emergency relief efforts AARP ... which could mean up to $500,000 in aid. The matching ...
    (Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
    (Date:1/15/2014)... Shire plc (LSE: SHP, NASDAQ: SHPG ) ... approval condition to the announced tender offer for all of the ... a result of the waiver, the transaction is no longer conditional ... on January 24, 2014 following the currently scheduled expiration time, subject ...
    Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
    (Date:7/10/2014)... severe illness and even death are likely to result ... influenza. Now, however, a team of researchers based at ... the order of infection, the bacteria Streptococcus pneumoniae ... bad case of the flu. , The researchers ... as a bacterial virulence factor, might protect macrophagesa type ...
    (Date:7/10/2014)... cancer were more likely to be diagnosed with ... and survived for shorter times than prostate cancer ... has found. , The negative outcomes may be ... against the mentally ill, depression,s impact on biological ... in his general health and disinterest in receiving ...
    (Date:7/10/2014)... who experience hot flashes are unlikely to talk much ... silent suffering if they are willing to try ... University case study., After seven weeks of hypnotic relaxation ... following prostate cancer surgery showed a drastic decrease not ... in sleep quality, according to the study., The Baylor ...
    (Date:7/9/2014)... the first time, researchers have access to detailed information ... health care. A new study, called Our Health Counts, ... challenges faced by urban Aboriginal people in Canada ... The findings, published today in BMJ Open , ... the general population. , Researchers interviewed 554 First Nations ...
    (Date:7/9/2014)... active in almost all types of cancer sends the ... help fuel a tumour,s uncontrolled growth, new research suggests. ... identified a molecular trigger responsible for ratcheting up activity ... that makes the building blocks cancer cells need to ... pathway, called SREBP, controls the flow of messages to ...
    Breaking Medicine News(10 mins):Health News:Bacterial colonization prior to catching the flu may protect against severe illness 2Health News:Depressed men with prostate cancer are diagnosed later stage, get less effective therapies 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Urban Aboriginal people face unique health challenges 2Health News:Signal may send cancer's cellular factories into overdrive 2
    ... $10,000 Donation to Local Food Bank, WASHINGTON, Oct. ... Roundy,s Supermarkets Inc. have launched a,campaign to demonstrate the ... campaign will be conducted in 155 Pick ,n Save, ... 7-31, 2007., Shoppers can sample a smoothie recipe ...
    ... Agency recently honored Proctor & Gamble, Cincinnati, Ohio, ... risks., The company accepted a 2007 Children,s ... with the Children,s Environmental Health,Workshop in Washington D.C. ... to ensure clean drinking water for children by ...
    ... MARKET FORECAST FOR THE DRUG, WALTHAM, Mass., Oct. ... is available to discuss the impact of the Food ... integrase inhibitor drug which blocks the ability of the ... inhibitors are a novel class of HIV drugs aimed ...
    ... Central venous catheters are commonly used to provide permanent ... inserting a catheter through large vessels, has been commonly ... in Hemodialysis International finds that this treatment may block ... vena cava syndrome (SVC syndrome), a highly serious complication ...
    ... pleased to,announce the launch of a 5-year cooperative agreement ... of the program is to strengthen,the breadth and depth ... health informatics and encourage new explorations of innovations,at the ... to:, -- Train and educate the public health ...
    ... Ariz., Oct. 12 Langford IC Systems, Inc.,announces ... the only,Parametric Release(TM) liquid chemical instrument processor. The ... system that cleans and,reprocesses instruments at the point ... hospitals, medical clinics, and in any medical setting ...
    Cached Medicine News:Health News:AISI and Roundy's Supermarkets Inc. Launch Program to Educate Shoppers on the Nutritional and Safety Benefits of Canned Food 2Health News:Proctor & Gamble Receives EPA Children's Environmental Health Excellence Award 2Health News:Impending FDA Approval Decision on the First HIV Integrase Inhibitor Can Have Significant Impact for Patients 2Health News:AMIA Announces Partnership with CDC to Enhance Public Health Informatics 2Health News:FDA Grants Clearance to Langford IC Systems, Inc. 2Health News:FDA Grants Clearance to Langford IC Systems, Inc. 3
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    Medicine Products: